Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
176.2 GBX | +0.23% | -2.70% | +9.01% |
May. 10 | StanChart exec sells shares; new Alphawave CFO buys | AN |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 4.81B 6.14B | Sales 2025 * | 4.99B 6.37B | Capitalization | 1.88B 2.4B |
---|---|---|---|---|---|
Net income 2024 * | 152M 194M | Net income 2025 * | 163M 208M | EV / Sales 2024 * | 0.52 x |
Net Debt 2024 * | 618M 788M | Net Debt 2025 * | 505M 645M | EV / Sales 2025 * | 0.48 x |
P/E ratio 2024 * |
12.9
x | P/E ratio 2025 * |
11.2
x | Employees | 50,000 |
Yield 2024 * |
2.27% | Yield 2025 * |
2.62% | Free-Float | 97.97% |
Latest transcript on Serco Group plc
1 day | +0.17% | ||
1 week | -2.70% | ||
Current month | -3.55% | ||
1 month | -4.12% | ||
3 months | -5.66% | ||
6 months | +12.40% | ||
Current year | +9.01% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Irwin
CEO | Chief Executive Officer | 59 | 13-03-31 |
Nigel Crossley
DFI | Director of Finance/CFO | 61 | 13-12-31 |
Paul Checketts
IRC | Investor Relations Contact | - | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Irwin
CEO | Chief Executive Officer | 59 | 13-03-31 |
Lynne Peacock
BRD | Director/Board Member | 70 | 17-06-30 |
John Rishton
CHM | Chairman | 66 | 16-09-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-29 | 176.4 | +0.34% | 87 023 |
24-05-28 | 175.8 | -3.46% | 2,347,092 |
24-05-24 | 182.1 | +0.61% | 4,491,758 |
24-05-23 | 181 | -0.33% | 1,659,091 |
24-05-22 | 181.6 | +0.33% | 3,070,369 |
Delayed Quote London S.E., May 29, 2024 at 03:28 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.01% | 2.41B | |
+11.23% | 68.01B | |
+5.94% | 17.22B | |
+12.95% | 13.88B | |
+22.61% | 13.81B | |
+15.26% | 10.1B | |
-21.24% | 6.76B | |
-4.24% | 5.98B | |
+0.93% | 5.15B | |
-2.01% | 4.91B |
- Stock Market
- Equities
- SRP Stock